http://www.renalandurologynews.com Latest articles from Renal and Urology News Prostate Cancer RUN Prostate Cancer News and review articles on prostate cancer. Prostate Cancer custserv@haymarketmedia.com no A new study of prostate cancer patients found that those who took statins were significantly less likely to die from their disease. http://www.renalandurologynews.com/statins-may-lower-pca-death-risk/article/297336/ Fri, 14 Jun 2013 10:00:00 GMT A new study of prostate cancer patients found that those who took statins were significantly less likely to die from their disease. RUN New urinals were designed to bring attention to prostate health and prostate cancer. http://www.renalandurologynews.com/video-game-urinals-help-boost-prostate-knowledge/article/297237/ Wed, 12 Jun 2013 13:00:00 GMT New urinals were designed to bring attention to prostate health and prostate cancer. RUN Highest versus lowest intake levels of black tea consumption was associated with a 33% decreased risk of stage IV disease. http://www.renalandurologynews.com/black-tea-may-lower-risk-of-advanced-prostate-cancer/article/297157/ Mon, 10 Jun 2013 20:00:00 GMT Highest versus lowest intake levels of black tea consumption was associated with a 33% decreased risk of stage IV disease. RUN Retreatment was well tolerated, with most adverse events mild to moderate in severity. http://www.renalandurologynews.com/sipuleucel-t-retreatment-may-benefit-men-with-mcrpc/article/296403/ Wed, 05 Jun 2013 12:07:57 GMT Retreatment was well tolerated, with most adverse events mild to moderate in severity. RUN Testosterone takes a long time to recover, so PSA levels in prostate cancer patients may remain low. http://www.renalandurologynews.com/psa-relapse-may-be-an-unreliable-post-adt-endpoint/article/296321/ Tue, 04 Jun 2013 17:11:13 GMT Testosterone takes a long time to recover, so PSA levels in prostate cancer patients may remain low. RUN High levels of M-CSF and IL-10 could be associated with reduced survival. http://www.renalandurologynews.com/two-cytokines-may-aid-crpc-patient-outcome-predictions/article/295928/ Mon, 03 Jun 2013 18:00:00 GMT High levels of M-CSF and IL-10 could be associated with reduced survival. RUN Gene expression profiles, including the 17-gene Genomic Prostate Score, may be able to predict prostate cancer aggressiveness when assessed in adjacent normal-appearing tissue. http://www.renalandurologynews.com/genes-in-normal-appearing-tissue-may-predict-pca-recurrence/article/295916/ Mon, 03 Jun 2013 13:44:25 GMT Gene expression profiles, including the 17-gene Genomic Prostate Score, may be able to predict prostate cancer aggressiveness when assessed in adjacent normal-appearing tissue. RUN While bone loss and reduction in bone mineral density are well known consequences of ADT, the main concern is increased risk of osteoporotic fractures. http://www.renalandurologynews.com/managing-bone-loss-associated-with-androgen-deprivation-therapy/article/297328/ Sat, 01 Jun 2013 04:00:00 GMT While bone loss and reduction in bone mineral density are well known consequences of ADT, the main concern is increased risk of osteoporotic fractures. RUN By itself or combined with external beam radiation therapy, it offers excellent oncologic outcomes. http://www.renalandurologynews.com/brachytherapy-a-good-option-for-younger-prostate-cancer-patients/article/295561/ Thu, 30 May 2013 18:42:57 GMT By itself or combined with external beam radiation therapy, it offers excellent oncologic outcomes. RUN Radical prostatectomy offers longer cancer-specific survival than radiotherapy after onset of metastatic disease. http://www.renalandurologynews.com/prostate-cancer-mortality-lower-with-radical-surgery/article/295072/ Tue, 28 May 2013 14:41:09 GMT Radical prostatectomy offers longer cancer-specific survival than radiotherapy after onset of metastatic disease. RUN Radium-223, a first-in-class drug, travels directly to the site of bone metastases, where it emits alpha particles that exert an anti-tumor effect. http://www.renalandurologynews.com/novel-drug-for-metastatic-prostate-cancer-approved/article/293460/ Wed, 15 May 2013 16:18:12 GMT Radium-223, a first-in-class drug, travels directly to the site of bone metastases, where it emits alpha particles that exert an anti-tumor effect. RUN Researchers studied 850 testosterone-deficient men who received 1,000 mg parenteral testosterone undecanoate six weeks after baseline and then every 12 weeks for up to five years. http://www.renalandurologynews.com/prostate-cancer-risk-not-higher-with-trt-use/article/293031/ Sun, 12 May 2013 12:37:17 GMT Researchers studied 850 testosterone-deficient men who received 1,000 mg parenteral testosterone undecanoate six weeks after baseline and then every 12 weeks for up to five years. RUN Shared decision-making about screening recommended for men aged 55-69 years. http://www.renalandurologynews.com/updated-prostate-cancer-screening-guidelines-announced/article/292385/ Tue, 07 May 2013 23:30:00 GMT Shared decision-making about screening recommended for men aged 55-69 years. RUN Median survival time from diagnosis improved by a median of 43 months from the pre-PSA to the post-PSA era. http://www.renalandurologynews.com/prostate-cancer-deaths-occurring-at-older-ages/article/292350/ Tue, 07 May 2013 21:00:00 GMT Median survival time from diagnosis improved by a median of 43 months from the pre-PSA to the post-PSA era. RUN In fact, men on testosterone replacement therapy (TRT) had a lower PCa rate than men not on TRT. http://www.renalandurologynews.com/prostate-cancer-risk-not-elevated-with-testosterone-replacement/article/292346/ Tue, 07 May 2013 19:00:00 GMT In fact, men on testosterone replacement therapy (TRT) had a lower PCa rate than men not on TRT. RUN Data support prophylactic use of a PDE-5 inhibitor in men receiving radiotherapy for prostate cancer. http://www.renalandurologynews.com/sildenafil-preserves-erectile-function-in-radiotherapy-patients/article/292345/ Tue, 07 May 2013 18:30:00 GMT Data support prophylactic use of a PDE-5 inhibitor in men receiving radiotherapy for prostate cancer. RUN This approach can reduce adverse events without impairing efficacy. http://www.renalandurologynews.com/intermittent-prostate-cancer-chemo-beneficial/article/292344/ Tue, 07 May 2013 17:51:42 GMT This approach can reduce adverse events without impairing efficacy. RUN